HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

KO 202125

a COX-2 inhibitor with antineoplastic activity; structure in first source
Also Known As:
KO-202125; KO202125
Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Cho, Sung-Dae: 2 articles (03/2011 - 01/2010)
2. Kong, Gu: 2 articles (03/2011 - 01/2010)
3. Kim, Hyun-Jun: 1 article (03/2011)
4. Lee, Jeong-Yeon: 1 article (03/2011)
5. Min, Young Ki: 1 article (03/2011)
6. Oh, Miyun: 1 article (03/2011)
7. Oh, Seung-Hyun: 1 article (03/2011)
8. Oian, Tingting: 1 article (03/2011)
9. Park, Ji-Hye: 1 article (03/2011)
10. Shin, Dong-Hui: 1 article (03/2011)

Related Diseases

1. Squamous Cell Carcinoma (Epidermoid Carcinoma)
2. Neoplasms (Cancer)
3. Breast Neoplasms (Breast Cancer)

Related Drugs and Biologics

1. sauristolactam
2. Enzymes
3. ErbB Receptors (EGF Receptor)
4. Cyclooxygenase 2 (Cyclooxygenase-2)
5. Estrogen Receptors
6. Gefitinib (Iressa)

Related Therapies and Procedures

1. Therapeutics